Deciphera to be acquired by Japan’s Ono in all-cash deal valued at $2.4 billion

Deciphera specializes in kinase drug discovery, where kinases are enyzmes that help regulate cellular function.

Deciphera to be acquired by Japan’s Ono in all-cash deal valued at $2.4 billion
Deciphera specializes in kinase drug discovery, where kinases are enyzmes that help regulate cellular function.